Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
B R Baker
Publications and source records attributed to B R Baker.
Irreversible enzyme inhibitors. LXXXVI. Hydrophobic bonding to dihydrofolic reductase. 8. Substituted-1-aryl-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines.
Explore the source record for details and available documents.
Aminopterin↗
Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine.
Explore the source record for details and available documents.
Animals↗
Irreversible enzyme inhibitors. XCII. Inhibition of xanthine oxidase by some purines and pyrimidines.
Explore the source record for details and available documents.
Allopurinol↗
Irreversible enzyme inhibitors. 93. Hydrophobic bonding to xanthine oxidase by some phenylpurines.
Explore the source record for details and available documents.
Enzymes↗
Irreversible enzyme inhibitors. 98. Hydrophobic interactions with succinoadenylate kinosynthetase and 9-substituted adenines.
Explore the source record for details and available documents.
Adenine↗
Irreversible enzyme inhibitors. 99. Inhibitors of thymidine phosphorylase. 7. Further studies on hydrophobic bonding with hydrocarbon substituents on acidic uracils.
Explore the source record for details and available documents.
Chemical Phenomena↗
Irreversible enzyme inhibitors. 100. Inhibitors of thymidine phosphorylase. 8. 6-(p-Bromoacetamidobenzyl)uracil, an active-site-directed irreversible inhibitor.
Explore the source record for details and available documents.
Binding Sites↗
Irreversible enzyme inhibitors. 73. Inhibitors of guanine deaminase. I. Mode of binding of guanine.
Explore the source record for details and available documents.
Aminohydrolases↗
Irreversible enzyme inhibitors. LXXIV. Inhibitors of guanine deaminase. II. Studies on bulk tolerance within enzyme-inhibitor complexes.
Explore the source record for details and available documents.
Aminohydrolases↗
Irreversible enzyme inhibitors. XCV. 8-(m-bromoacetamidobenzylthio)hypoxanthine, an active-site-directed irreversible inhibitor of xanthine oxidase.
Explore the source record for details and available documents.
Animals↗
Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
Explore the source record for details and available documents.
Animals↗
Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
Explore the source record for details and available documents.
Aminohydrolases↗
Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase.
Explore the source record for details and available documents.
Aminohydrolases↗
Irreversible enzyme inhibitors. CIV. Inhibitors of thymidine phosphorylase. 8. Further studies on hydrophobic bonding with 6-substituted uracils.
Explore the source record for details and available documents.
Binding Sites↗
Irreversible enzyme inhibitors. CV. Differential irreversible inhibition of vertebrate dihydrofolic reductases by derivatives of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazines substituted with a terminal sulfonyl fluoride.
Explore the source record for details and available documents.
Animals↗
Irreversible enzyme inhibitors. CVI. Proteolytic enzymes. I. Bulk tolerances in trypsin-inhibitor complexes.
Explore the source record for details and available documents.
Amidines↗
Irreversible enzyme inhibitors. CVII. Proteolytic enzymes. II. Bulk tolerance within chymotrypsin-inhibitor complexes.
Explore the source record for details and available documents.
Amides↗